BRET BAKER: Open Payments
NPI 1912909789 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 21 payments from 10 companies in 2025. Trend: 2023 $856 · 2024 $611 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $192 |
| Novo Nordisk Inc | 4 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Lilly USA, LLC | 2 | $37 |
| PFIZER INC. | 2 | $36 |
| ABBVIE INC. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $32 |
| Exact Sciences Corporation | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Corcept Therapeutics | 1 | $15 |
Products named: BREZTRI, Ozempic, CAPLYTA, MOUNJARO, ELIQUIS, VOQUEZNA, AIRSUPRA, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
